4//SEC Filing
ANI PHARMACEUTICALS INC 4
Accession 0001144204-15-016474
$ANIPCIK 0001023024operating
Filed
Mar 15, 8:00 PM ET
Accepted
Mar 16, 5:32 PM ET
Size
5.1 KB
Accession
0001144204-15-016474
Insider Transaction Report
Form 4
RAYNOR DANIEL
Director
Transactions
- Sale
Common Stock
2015-03-12$63.00/sh−200,000$12,600,000→ 324,182 total(indirect: See Footnote)
Footnotes (1)
- [F1]These shares are held by Argentum Capital Partners II, L.P. (ACP II). Argentum Investments, LLC is the managing member of Argentum Partners II, LLC, which is the general partner of ACP II. Daniel Raynor is a co-managing member of Argentum Investments, LLC. Mr. Raynor disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest therein.
Documents
Issuer
ANI PHARMACEUTICALS INC
CIK 0001023024
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001023024
Filing Metadata
- Form type
- 4
- Filed
- Mar 15, 8:00 PM ET
- Accepted
- Mar 16, 5:32 PM ET
- Size
- 5.1 KB